Studies have shown that the subjects with diabetes (47), obesity (44), or MetS (48), had an increased activity of CYP2E1, which might be associated with both hepatic toxin metabolism (49, 50) and the development of liver fibrosis (43). The gene discussed is CYP2E1; the disease is metabolic syndrome.